4月8日,据外媒报道,细胞分析公司Celcuity宣布与辉瑞公司达成全球许可协议,辉瑞将gedatolisib(一种1b期pan-PI3K / mTOR抑制剂)专有权授予给Celcuity。Gedatolisib正在临床开发中,用于治疗ER + / HER2-阴性的晚期或转移性乳腺癌患者。
根据许可协议条款,辉瑞向Celcuity提...查看全文
美股 美股开盘 | 三大指数涨跌不一,搜狐(SOHU.US)涨超13% 2021年4月9日 20:31:45 智通财经APP获悉,4月9日(周五)美股开盘,三大指数涨跌不一。截至发稿,道指涨0.18%,标普500指数跌0.03%,纳指跌0.41%。 个股消息 细胞分析公司Celcuit... 网页链接
格隆汇4月9日丨Celcuity(CELC.US)盘前大涨38.78%报19.86美元。公司周四表示,已与辉瑞公司签署了一项全球许可协议,获得了开发和商业化辉瑞Gedatolisib的全球许可。Gedatolisib正处于临床开发阶段,用于治疗某些类型的乳腺癌患者。Celcuity表示:“来自103... 网页链接
$Celcuity Inc.(CELC)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2017-11-07 AccNo: 0001209191-17-059583 Size: 13 KB 网页链接
$Celcuity Inc.(CELC)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-10-25 AccNo: 0001144204-17-054127 Size: 71 KB 网页链接
$Celcuity Inc.(CELC)$ CERTNAS [Paper] - Certification by the National Association of Securities Dealers Automated Quotation approving securities for l Film#: 17010891 Filed: 2017-09-19 AccNo: 9999999997-17-008767 Size: 1 KB 网页链接
$Celcuity Inc.(CELC)$ CERTNAS [Paper] - Certification by the National Association of Securities Dealers Automated Quotation approving securities for l Film#: 17010891 Filed: 2017-09-19 AccNo: 9999999997-17-008767 Size: 1 KB 网页链接
$Celcuity Inc.(CELC)$ EFFECT - Notice of Effectiveness Filed: 2017-09-19 AccNo: 9999999995-17-002398 Size: 1 KB 网页链接
$Celcuity Inc.(CELC)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2017-09-20 AccNo: 0001571049-17-007983 Size: 2 MB 网页链接
$Celcuity Inc.(CELC)$ S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] Filed: 2017-09-19 AccNo: 0001571049-17-007969 Size: 60 KB 网页链接
$Celcuity Inc.(CELC)$ CORRESP [Cover] - Correspondence Filed: 2017-09-18 AccNo: 0001571049-17-007958 Size: 8 KB 网页链接
$Celcuity Inc.(CELC)$ CORRESP [Cover] - Correspondence Filed: 2017-09-18 AccNo: 0001571049-17-007957 Size: 5 KB 网页链接
$Celcuity Inc.(CELC)$ CORRESP [Cover] - Correspondence Filed: 2017-09-14 AccNo: 0001571049-17-007888 Size: 8 KB 网页链接